BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24 Stock

Warrant

DE000VD3VZN9

Market Closed - Boerse Frankfurt Warrants 13:50:33 2024-05-31 EDT
0.121 EUR -16.55% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24
Current month-46.70%
1 month-46.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 0.121 -16.55%
24-05-30 0.145 +18.85%
24-05-29 0.122 -.--%
24-05-28 0.122 -29.48%
24-05-27 0.173 -3.35%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 01:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3VZN
ISINDE000VD3VZN9
Date issued 2024-04-10
Strike 150 $
Maturity 2024-12-20 (203 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.29
Lowest since issue 0.118
Spread 0.01
Spread %7.52%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus